Picture of MabCure logo

MBCI — MabCure Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m+37.67%
3m+3.07%
6m+209.46%
1yr+105.54%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-68.25%
50d MA+9.4%
200d MA+42.65%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-312.43%
Return on Equity-125.15%
Operating Margin-2421.95%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 201231st Dec 2013
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2012 / 2013

Blurred out image of MabCure EPS forecast chart

Profile Summary

Mabcure, Inc., (Mabcure) is a development-stage company. The Company is engaged in the business of developing and commercializing its antibody technology for the early detection of cancer and for the creation of therapeutics against cancer. The Company originally was in the business of developing a detergent for removing pesticides from fruits and vegetables. During the year ended December 31, 2011, the Company has not generated any revenue.

Directors

    Last Annual
    December 31st, 2011
    Last Interim
    December 31st, 2011
    Incorporated
    May 8th, 2006
    Public Since
    June 21st, 2001
    No. of Shareholders
    11
    No. of Employees
    3
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    781,085,980
    Blurred out image of a map
    Address
    275 Palm Beach Drive, Jolly Harbour, BROOKLYN, 89701-4201
    Web
    Phone
    +1 2687208969
    Auditors
    Rotenberg Meril Solomon Bertiger & Guttilla, P.C.

    MBCI Share Price Performance

    Similar to MBCI

    Picture of Acura Pharmaceuticals logo

    Acura Pharmaceuticals

    us flag iconPink Sheets on Nasdaq

    Picture of Adhera Therapeutics logo

    Adhera Therapeutics

    us flag iconPink Sheets on Nasdaq

    Advantis

    us flag iconPink Sheets on Nasdaq

    Picture of Advaxis logo

    Advaxis

    us flag iconPink Sheets on Nasdaq

    Picture of Adynxx logo

    Adynxx

    us flag iconPink Sheets on Nasdaq

    FAQ

    Or unlock with your email

    Or unlock with your email